NEW YORK, Jan. 23, 2017 /PRNewswire/ -- Hernia mesh lawsuits involving Atrium Medical Corp.'s C-Qur line of polypropylene surgical mesh are beginning to move forward in a multidistrict litigation recently established in the U.S. District Court, District of New Hampshire. The Court issued its first Case Management Order on January 13th, which, among other things, stays discovery in all pending claims until the proceeding's initial case management conference. A discovery schedule will be established at the conference, which is to be convened on Friday, February 23rd at 10:00 a.m. (IN RE: Atrium Medical Corp. C-Qur Mesh Products Liability Litigation – MDL No. 2753)
"Our Firm has heard from numerous individuals who claim to have experienced painful complications due to allegedly defective hernia mesh products. We are pleased that the Atrium C-Qur litigation is moving forward, and will continue to closely monitor developments in the proceeding," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free, no-obligation legal reviews to individuals who experienced recurrence and revision following implantation of hernia mesh products, including Ethicon, Inc.'s Physiomesh devices.
Hernia Mesh Litigation
At least 21 hernia mesh lawsuits are now pending in the Atrium C-Qur litigation underway in New Hampshire. The proceeding was established by the U.S. Judicial Panel on Multidistrict Litigation last month to allow all such federal claims to undergo coordinated pretrial proceedings. Plaintiffs pursuing these lawsuits claim that C-Qur mesh causes an inflammatory response that may result in improper fixation, bowel adhesions and other severe complications. They further claim that Atrium was aware of these alleged design defects, yet concealed that knowledge and failed to provide appropriate safety warnings to doctors and patients.
Ethicon, Inc. is also facing a growing number of claims involving its Physiomesh Flexible Composite Mesh product in courts throughout the U.S. The company announced a worldwide market withdrawal of the product on May 25, 2016, after unpublished registry data indicated that Physiomesh was associated with higher recurrence and revision rates after laparoscopic ventral hernia repair compared to another set of mesh. A Physiomesh lawsuit pending in the U.S. District Court, Southern District of Illinois, will likely be the first case to go to trial, with jury selection scheduled to begin on January 22, 2018. (Case No. 3:16-cv-00368-JPG-PMF)
Bernstein Liebhard LLP is offering free, no-obligation legal reviews to patients who may have suffered harm due to Physiomesh Flexible Composite Mesh or similar products. To learn more about filing a hernia mesh lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
SOURCE Bernstein Liebhard LLP